▲ Peaking
Business
FDA Approves Centanafadine for ADHD in Children, Adolescents, and Adults
The FDA has approved Otsuka's Simtriyo (centanafadine), the first new-class ADHD medication for pediatric and adult patients in decades.
mykxlg.com
Coverage by mykxlg.com as tracked by Newsylist.
1trends covered
0broke first
1articles tracked